Your browser doesn't support javascript.
loading
Co-occurrence of mutations in NF1 and other susceptibility genes in pheochromocytoma and paraganglioma.
Mellid, Sara; Gil, Eduardo; Letón, Rocío; Caleiras, Eduardo; Honrado, Emiliano; Richter, Susan; Palacios, Nuria; Lahera, Marcos; Galofré, Juan C; López-Fernández, Adriá; Calatayud, Maria; Herrera-Martínez, Aura D; Galvez, María A; Matias-Guiu, Xavier; Balbín, Milagros; Korpershoek, Esther; Lim, Eugénie S; Maletta, Francesca; Lider, Sofia; Fliedner, Stephanie M J; Bechmann, Nicole; Eisenhofer, Graeme; Canu, Letizia; Rapizzi, Elena; Bancos, Irina; Robledo, Mercedes; Cascón, Alberto.
Afiliação
  • Mellid S; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Gil E; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Letón R; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Caleiras E; Histopathology Core Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Honrado E; Anatomical Pathology Service, Hospital of León, León, Spain.
  • Richter S; Institute for Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Palacios N; Endocrinology Department, University Hospital Puerta de Hierro, Madrid, Spain.
  • Lahera M; Endocrinology and Nutrition Department, La Princesa University Hospital, Madrid, Spain.
  • Galofré JC; Department of Endocrinology, Clínica Universidad de Navarra, Pamplona, Spain.
  • López-Fernández A; Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Calatayud M; Department of Endocrinology and Nutrition, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Herrera-Martínez AD; Endocrinology and Nutrition Service, Reina Sofia University Hospital, Cordoba, Spain.
  • Galvez MA; Endocrinology and Nutrition Service, Reina Sofia University Hospital, Cordoba, Spain.
  • Matias-Guiu X; Department of Pathology, Bellvitge University Hospital, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.
  • Balbín M; Molecular Oncology Laboratory, Instituto Universitario de Oncologia del Principado de Asturias, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Korpershoek E; Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, Netherlands.
  • Lim ES; Department of Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
  • Maletta F; Pathology Unit , Department of Laboratory Medicine, Azienda Ospedaliero-Universitaria (AOU) Città della Salute e della Scienza di Torino, Torino, Italy.
  • Lider S; Endocrinology Department, National Institute of Endocrinology, Bucharest, Romania.
  • Fliedner SMJ; First Department of Medicine, University Medical Center Schleswig-Holstein, Lübeck, Germany.
  • Bechmann N; Institute for Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Eisenhofer G; Institute for Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Canu L; Department of Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Rapizzi E; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Bancos I; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Robledo M; Division of Endocrinology, Metabolism and Nutrition, Mayo Clinic, Rochester, MN, United States.
  • Cascón A; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Front Endocrinol (Lausanne) ; 13: 1070074, 2022.
Article em En | MEDLINE | ID: mdl-36760809

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Paraganglioma / Feocromocitoma / Neoplasias das Glândulas Suprarrenais Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Front Endocrinol (Lausanne) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Paraganglioma / Feocromocitoma / Neoplasias das Glândulas Suprarrenais Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Front Endocrinol (Lausanne) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha